Dopamine Is a Pathogenetic Factor in HIV-Induced Neuro-AIDS
During the first years of the AIDS pandemic caused by the human immunodeficiency virus (HIV), a progressive, dementing illness, later called simply Neuro-AIDS, AIDS dementia complex or HIV dementia was defined as one of the consequences of the viral brain infection (Navia et al., 1986a; Navia et al., 1986b). According to WHO report, December 2000, it is estimated that around 36 million people world wide are infected with HIV. One-third of them is expected to develop HIV-dementia. HIV is the leading cause of dementia in people less than 60 years of age (Janssen et al., 1992; McArthur et al., 1993).
KeywordsHuman immunodefIciency Virus Human Immunodeficiency Virus Type Human immunodefIciency Virus Infection Simian Immunodeficiency Virus Infection Thioctic Acid
Unable to display preview. Download preview PDF.
- Czub, S., Koutsilieri, E., Sopper, S., Czub, M., Stahl-Hennig, C., Müller, J. G., Pedersen, V., Gsell, W., Heeney, J. L., Gerlach, M., Gosztonyi, G., Riederer, P., and ter Meulen, V., 2001, Enhancement of CNS pathology in early simian immunodeficiency virus infection by dopaminergic drugs, Acta Neuropathol. 101:85–91.PubMedGoogle Scholar
- McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., Graham, N. M., McArthur, J. H., Seines, O. A., Jacobson, L. P. et al, 1993, Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study, Neurology 43:2245–2252.PubMedCrossRefGoogle Scholar